Federal Circuit Dismisses Apotex Suit V. Pfizer Over Accupril Patent
The U.S. Court of Appeals for the Federal Circuit has dismissed Canadian generics maker Apotex Inc.'s lawsuit against Pfizer, Inc. after Pfizer covenanted not to sue Apotex for infringement of a...To view the full article, register now.
Already a subscriber? Click here to view full article